Evidence map›Paper›PMID 24875179›Full record

ArticleNeuroscience2014

PTEN degradation after ischemic stroke: a double-edged sword.

W Li, R Huang, Z Chen, L-J Yan, J W Simpkins, S-H Yang

Abstract read
In one paragraph

Article in Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. Neuroprotective and regenerative roles of intranasal Wnt-3a administration after focal ischemic stroke in mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

W LiDepartment of Pharmacology and Neuroscience, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.
R HuangDepartment of Pharmacology and Neuroscience, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.
Z ChenDepartment of Pharmacology and Neuroscience, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.
L-J YanDepartment of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.
J W SimpkinsDepartment of Physiology and Pharmacology, Center for Neuroscience, West Virginia University Health Science Center, 1 Medical Center Drive, Morgantown, WV 26506, United States.
S-H YangDepartment of Pharmacology and Neuroscience, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, United States. Electronic address: shaohua.yang@unthsc.edu.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
ROLE OF MITHOCHONDRIAL ERB IN NEURONAL VULNDERABILITY TO NEUROTOXIC STRESSP01AG027956 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SINGH, MEHARVAN · 2007 to 2017
$11.3M
Neuroglobin: cell metabolism and neuroprotectionR01NS088596 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2014 to 2018
$1.6M
Vascular Cognitive Impairment Induced by Ischemic Stroke: mechanism and therapyR01NS054651 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2008 to 2012
$1.6M
Dietary targeting of dihydrolipoamide dehydrogenase for stroke toleranceR01NS079792 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI FORSTER, MICHAEL J., YAN, LIANG-JUN · 2013 to 2017
$1.3M
Interaction of Estrogen and Tissue Plasminogen ActivatorR01NS054687 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2008 to 2011
$1.0M
Establishment of inducible astrocyte specific p38 MAPK knockout mouse lineR21NS087209 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI YANG, SHAOHUA · 2014 to 2015
$402k
NIA NIH HHS P01 AG027956NIGMS NIH HHS U54 GM104942NINDS NIH HHS R01 NS054651NINDS NIH HHS R01NS054651NINDS NIH HHS R01 NS054687NINDS NIH HHS R01NS054687NINDS NIH HHS R01 NS079792NINDS NIH HHS R01NS079792NINDS NIH HHS R01 NS088596NINDS NIH HHS R21 NS087209
6 · The paper itself

Abstract

Tumor suppressor phosphatase and tensin homolog (PTEN) is highly expressed in neurons and PTEN inhibition has been reported to be neuroprotective against ischemic stroke in experimental models. On the other hand, PTEN deletion has been shown to lead to cognitive impairment. In the current study, we examined the expression and functions of PTEN in an ischemic stroke rodent model. We found rapid S-nitrosylation and degradation of PTEN after cerebral ischemia/reperfusion injury. PTEN degradation leads to activation of Akt. PTEN partial deletion or PTEN inhibition increased the expression of GABAA receptor (GABAAR) γ2 subunit and enhanced GABAA receptor current. After cerebral ischemia, increased expression of GABAAR γ2 subunit was observed in the ischemia region and the penumbra area. We also observed PTEN loss in astrocytes after cerebral ischemia. Astrocytic PTEN partial knockout increased astrocyte activation and exacerbated ischemic damage. We speculated that ischemic stroke induced neuronal PTEN degradation, hence enhanced GABAA receptor-medicated neuronal activity inhibition which could attenuate excitotoxicity and provide neuroprotection during the acute phase after stroke, while inhibiting long-term functional recovery and contributing to vascular cognitive impairment after stroke. On the other hand, ischemic stroke induced astrocytic PTEN loss and enhanced ischemic damage and astrogliosis. Taken together, our study indicates that ischemic stroke induces rapid PTEN degradation in both neurons and astrocytes which play both protective and detrimental action in a spatiotemporal- and cell-type-dependent manner. Our study provides critical insight for targeting PTEN signaling pathway for stroke treatment.

Indexed as

AnimalsAstrocytesBrainBrain IschemiaCell LineHippocampusMice, Inbred C57BLMice, KnockoutNeuronsProteolysisPTEN PhosphohydrolaseReceptors, GABA-AReperfusion InjurySignal TransductionStrokePTEN PhosphohydrolasePten protein, ratReceptors, GABA-AdegradationGABAgliosisnitrosylationPTENstroke

Identifiers

PMID24875179
PMCPMC4167413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.